Neuromuscular electrical stimulation improves clinical and physiological function in COPD patients.

Area of Science:

• Pulmonary Medicine
• Rehabilitation Science
• Exercise Physiology

Background:

• Chronic obstructive pulmonary disease (COPD) is characterized by impaired muscle performance and exercise intolerance.
• Dynamic hyperinflation (DH) is a significant contributor to dyspnea in COPD patients.
• The effect of neuromuscular electrical stimulation (NMES) on DH in COPD has not been previously investigated.

Purpose of the Study:

• To investigate the effect of short-term, high-frequency NMES on dynamic hyperinflation (DH) in patients with COPD.
• To assess the impact of NMES on exercise tolerance, pulmonary function, and quality of life in COPD patients.

Main Methods:

• A randomized controlled trial involving 20 COPD patients allocated to either NMES (n=11) or a control group (n=9).
• NMES was applied to quadriceps muscles for 8 weeks (5 days/week, twice/day, 45 min/session).
• Evaluated outcomes included pulmonary function, exercise tolerance (Tlim, 6-MWTD), dyspnea scores, quality of life (SGRQ), TNF-α, and β-endorphin levels.

Main Results:

• NMES significantly increased FEV1, FEV1/FVC, 6-minute walk distance (6-MWD), and time to exercise limitation (Tlim) compared to the control group (P < 0.01).
• NMES reduced Borg dyspnea scores (BDS) and St. George's Respiratory Questionnaire (SGRQ) scores (P < 0.01).
• NMES decreased TNF-α and increased β-endorphin levels (P < 0.001), correlating positively with respiratory improvements.

Conclusions:

• Eight weeks of NMES effectively reduces perceived dyspnea during exercise in COPD patients.
• NMES treatment leads to improvements in pulmonary function, exercise tolerance, and quality of life.
• Observed benefits may be linked to enhanced vasodilatory function and reduced inflammatory responses.